Saudi Arabia Pharmaceuticals Market Size & Share Analysis - Trends, Drivers, Competitive Landscape, and Forecasts (2024 - 2030)
Get a Comprehensive Overview of the Saudi Arabia Pharmaceuticals Market Report Prepared by P&S Intelligence, Segmented by Product Type (Prescription Drugs, Over-the-Counter Drugs), Distribution Channel (Retail, Online, Hospital), Indication (Cardiovascular Disease, Cancer, Diabetes, Infectious Disease, Obesity), and Geographic Regions. This Report Provides Insights from 2019 to 2030.
Chapter 1. Research Scope
1.1. Research Objectives
1.2. Market Definition
1.3. Analysis Period
1.4. Market Size Breakdown by Segments
1.4.1. Market size breakdown, by product type
1.4.2. Market size breakdown, by distribution channel
1.4.3. Market size breakdown, by indication
1.4.4. Market size breakdown, by province
1.5. Market Data Reporting Unit
1.5.1. Value
1.6. Key Stakeholders
Chapter 2. Research Methodology
2.1. Secondary Research
2.1.1. Paid
2.1.2. Unpaid
2.1.3. P&S Intelligence database
2.2. Primary Research
2.3. Market Size Estimation
2.4. Data Triangulation
2.5. Currency Conversion Rates
2.6. Assumptions for the Study
2.7. Notes and Caveats
Chapter 3. Executive Summary
Chapter 4. Market Indicators
Chapter 5. Industry Outlook
5.1. Market Dynamics
5.1.1. Trends
5.1.2. Drivers
5.1.3. Restraints/challenges
5.1.4. Impact analysis of drivers/restraints
5.2. Impact of COVID-19
5.3. Porter’s Five Forces Analysis
5.3.1. Bargaining power of buyers
5.3.2. Bargaining power of suppliers
5.3.3. Threat of new entrants
5.3.4. Intensity of rivalry
5.3.5. Threat of substitutes
Chapter 6. Saudi Arabia Market
6.1. Overview
6.2. Market Revenue, by Product Type (2019–2030)
6.3. Market Revenue, by Distribution Channel (2019–2030)
6.4. Market Revenue, by Indication (2019–2030)
6.5. Market Revenue, by Province (2019–2030)
Chapter 7. Competitive Landscape
7.1. List of Market Players and their Offerings
7.2. Competitive Benchmarking of Key Players
7.3. Product Benchmarking of Key Players
7.4. Recent Strategic Developments
Chapter 8. Company Profiles
8.1. SPIMACO Addwaeih
8.1.1. Business overview
8.1.2. Product and service offerings
8.1.3. Key financial summary
8.2. Tabuk Pharmaceuticals Manufacturing Company
8.2.1. Business overview
8.2.2. Product and service offerings
8.2.3. Key financial summary
8.3. Hikma Pharmaceuticals PLC
8.3.1. Business overview
8.3.2. Product and service offerings
8.3.3. Key financial summary
8.4. Jamjoom Pharmaceuticals Factory Company SJSC
8.4.1. Business overview
8.4.2. Product and service offerings
8.4.3. Key financial summary
8.5. Modern Pharmaceutical Company LLC
8.5.1. Business overview
8.5.2. Product and service offerings
8.5.3. Key financial summary
8.6. Amico pharma
8.6.1. Business overview
8.6.2. Product and service offerings
8.6.3. Key financial summary
8.7. Nahdi Medical Company
8.7.1. Business overview
8.7.2. Product and service offerings
8.7.3. Key financial summary
8.8. SIPCO LLC
8.8.1. Business overview
8.8.2. Product and service offerings
8.8.3. Key financial summary
8.9. Pfizer Inc.
8.9.1. Business overview
8.9.2. Product and service offerings
8.9.3. Key financial summary
8.10. AstraZeneca plc
8.10.1. Business overview
8.10.2. Product and service offerings
8.10.3. Key financial summary
8.11. AJA Pharma Co.
8.11.1. Business overview
8.11.2. Product and service offerings
8.11.3. Key financial summary
8.12. Novartis AG
8.12.1. Business overview
8.12.2. Product and service offerings
8.12.3. Key financial summary
Chapter 9. Appendix
9.1. Abbreviations
9.2. Sources and References
9.3. Related Reports
